Innate Pharma announces initial Phase 1 data for IPH4502, showing potential for advanced solid tumors, especially in urothelial cancer patients.
| Name | Innate Pharma SA |
|---|---|
| CIK | 0001598599 |
| Tickers | IPHA, IPHYF |
| Exchanges | Nasdaq, OTC |
| Entity type | other |
| Category | Accelerated filer |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 000000000 |
| LEI | 9695002Y8420ZB8HJE29 |
| Fiscal year end | 1231 |
| State of incorporation | I0 France |
| Phone | 33430303030 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 0 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Innate Pharma announces initial Phase 1 data for IPH4502, showing potential for advanced solid tumors, especially in urothelial cancer patients.
Innate Pharma shares its third quarter financial update, showcasing advancements in its clinical pipeline and a strong cash position of €96.8 million.
Innate Pharma has revised the timing for the PACIFIC-9 Phase 3 trial data readout to H1 2027, reflecting the event-driven nature of the study.
Innate Pharma SA announces participation in Stifel and Jefferies Healthcare Conferences, highlighting its commitment to investor engagement and innovation.
Innate Pharma SA will hold a conference call on November 5, 2026, to discuss its Q3 2026 business and financial update.
341 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-18 | 6-K | 6-K | 0001628280-26-074642 | 001-39084 | 261567936 | 34 | 41025 | |||
| 2026-11-12 | 6-K | 6-K | 0001628280-26-073032 | 001-39084 | 261542471 | 34 | 29849 | |||
| 2026-11-05 | 6-K | 6-K | 0001628280-26-070497 | 001-39084 | 261524567 | 34 | 44498 | |||
| 2026-10-27 | 6-K | 6-K | 0001628280-26-067408 | 001-39084 | 261487323 | 34 | 23262 | |||
| 2026-10-21 | 6-K | 6-K | 0001628280-26-066591 | 001-39084 | 261474099 | 34 | 22675 | |||
| 2026-10-20 | 6-K | 6-K | 0001628280-26-066382 | 001-39084 | 261470437 | 34 | 23878 | |||
| 2026-09-17 | 6-K | 6-K | 0001628280-26-062360 | 001-39084 | 261385168 | 34 | 236560 | |||
| 2026-09-17 | 6-K | 6-K | 0001598599-26-000010 | 001-39084 | 261385166 | 34 | 9227853 | 1 | 1 | |
| 2026-09-17 | 6-K | 6-K | 0001628280-26-062357 | 001-39084 | 261385161 | 34 | 23701 | |||
| 2026-09-10 | 6-K | 6-K | 0001628280-26-061214 | 001-39084 | 261369586 | 34 | 22101 | |||
| 2026-09-02 | 6-K | 6-K | 0001628280-26-059963 | 001-39084 | 261352628 | 34 | 21991 | |||
| 2026-08-19 | 6-K | 6-K | 0001628280-26-057935 | 001-39084 | 261295145 | 34 | 363301 | |||
| 2026-08-14 | 6-K | 6-K | 0001628280-26-056913 | 001-39084 | 261275776 | 34 | 20686 | |||
| 2026-08-10 | 6-K | 6-K | 0001628280-26-054966 | 001-39084 | 261256040 | 34 | 48568 | |||
| 2026-07-23 | 6-K | 6-K | 0001628280-26-049273 | 001-39084 | 261195092 | 34 | 23329 | |||
| 2026-07-21 | 6-K | 6-K | 0001598599-26-000008 | 001-39084 | 261188102 | 34 | 29819 | |||
| 2026-06-22 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000950103-26-009261 | 005-91173 | 261104968 | 34 | 6717 | |||
| 2026-05-22 | 6-K | 6-K | 0001628280-26-037515 | 001-39084 | 261010649 | 34 | 20882 | |||
| 2026-05-19 | 6-K | 6-K | 0001628280-26-036122 | 001-39084 | 26995747 | 34 | 21196 | |||
| 2026-05-13 | 6-K | 6-K | 0001628280-26-034383 | 001-39084 | 26971044 | 34 | 45908 | |||
| 2026-05-12 | 6-K | 6-K | 0001628280-26-033831 | 001-39084 | 26965700 | 34 | 24446 | |||
| 2026-05-06 | 6-K | 6-K | 0001628280-26-030874 | 001-39084 | 26945670 | 34 | 23564 | |||
| 2026-04-23 | 6-K | 6-K | 0001628280-26-026676 | 001-39084 | 26885368 | 34 | 22728 | |||
| 2026-04-17 | 6-K | 6-K | 0001628280-26-025688 | 001-39084 | 26871140 | 34 | 35723 | |||
| 2026-04-13 | 6-K | 6-K | 0001628280-26-024822 | 001-39084 | 26856393 | 34 | 24876 | |||
| 2026-04-13 | 6-K | 6-K | 0001628280-26-024819 | 001-39084 | 26856376 | 34 | 24580 | |||
| 2026-04-10 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000950103-26-005593 | 005-91173 | 26853246 | 34 | 6836 | |||
| 2026-04-08 | 6-K | 6-K | 0001628280-26-024144 | 001-39084 | 26846441 | 34 | 26649 | |||
| 2026-04-03 | 6-K | 6-K | 0001628280-26-023471 | 001-39084 | 26836769 | 34 | 22005 | |||
| 2026-04-02 | 6-K | 6-K | 0001628280-26-022913 | 001-39084 | 26830469 | 34 | 22438 | |||
| 2026-04-01 | 20-F | 20-F | 0001598599-26-000005 | 001-39084 | 26824543 | 34 | 30816776 | 1 | 1 | |
| 2026-03-26 | 6-K | 6-K | 0001628280-26-021168 | 001-39084 | 26794189 | 34 | 190993 | |||
| 2026-03-19 | 6-K | 6-K | 0001628280-26-019623 | 001-39084 | 26772388 | 34 | 24138 | |||
| 2026-03-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950103-26-003227 | 005-91173 | 26722242 | 34 | 6738 | |||
| 2026-02-18 | 6-K | 6-K | 0001628280-26-008778 | 001-39084 | 26645321 | 34 | 22634 | |||
| 2026-02-06 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-26-011298 | 005-91173 | 26605571 | 34 | 42402 | |||
| 2026-01-07 | 6-K | 6-K | 0001628280-26-001094 | 001-39084 | 26513891 | 34 | 25066 | |||
| 2025-12-22 | 6-K | 6-K | 0001628280-25-058386 | 001-39084 | 251589345 | 34 | 25089 | |||
| 2025-12-11 | 6-K | 6-K | 0001628280-25-056412 | 001-39084 | 251563438 | 34 | 23994 | |||
| 2025-11-28 | 6-K | 6-K | 0001628280-25-054231 | 001-39084 | 251532569 | 34 | 27522 | |||
| 2025-11-17 | 6-K | 6-K | 0001628280-25-052474 | 001-39084 | 251489178 | 34 | 25807 | |||
| 2025-11-13 | 6-K | 6-K | 0001628280-25-051813 | 001-39084 | 251475177 | 34 | 45548 | |||
| 2025-11-10 | 6-K | 6-K | 0001628280-25-050768 | 001-39084 | 251464206 | 34 | 32476 | |||
| 2025-11-05 | 6-K | 6-K | 0001628280-25-049202 | 001-39084 | 251451604 | 34 | 27199 | |||
| 2025-10-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950103-25-013417 | 005-91173 | 251405386 | 34 | 6739 | |||
| 2025-10-15 | 6-K | 6-K | 0001628280-25-045045 | 001-39084 | 251393344 | 34 | 32704 | |||
| 2025-09-17 | 6-K | 6-K | 0001598599-25-000077 | 001-39084 | 251318760 | 34 | 254838 | |||
| 2025-09-17 | 6-K | 6-K | 0001598599-25-000075 | 001-39084 | 251318756 | 34 | 9664313 | 1 | 1 | |
| 2025-09-15 | 6-K | 6-K | 0001598599-25-000073 | 001-39084 | 251313082 | 34 | 22227 | |||
| 2025-09-10 | 6-K | 6-K | 0001598599-25-000071 | 001-39084 | 251304594 | 34 | 27977 | |||
| 2025-09-02 | 6-K | 6-K | 0001598599-25-000070 | 001-39084 | 251283166 | 34 | 24150 | |||
| 2025-08-04 | 6-K | 6-K | 0001598599-25-000067 | 001-39084 | 251177942 | 34 | 23898 | |||
| 2025-07-29 | 6-K | 6-K | 0001598599-25-000065 | 001-39084 | 251157437 | 34 | 23374 | |||
| 2025-07-07 | 6-K | 6-K | 0001598599-25-000062 | 001-39084 | 251106901 | 34 | 26704 | |||
| 2025-06-17 | 6-K | 6-K | 0001598599-25-000060 | 001-39084 | 251051760 | 34 | 23357 | |||
| 2025-06-13 | 6-K | 6-K | 0001598599-25-000059 | 001-39084 | 251044641 | 34 | 34376 | |||
| 2025-05-30 | 144 | xsl144X01/primary_doc.xml | 0000950103-25-006700 | 001-39084 | 251006655 | 33 | 8506 | |||
| 2025-05-27 | 6-K | 6-K | 0001598599-25-000057 | 001-39084 | 25984065 | 34 | 26362 | |||
| 2025-05-23 | 6-K | 6-K | 0001598599-25-000055 | 001-39084 | 25979194 | 34 | 27349 | |||
| 2025-05-23 | 6-K | 6-K | 0001598599-25-000054 | 001-39084 | 25979191 | 34 | 70903 | |||
| 2025-05-19 | 6-K | 6-K | 0001598599-25-000053 | 001-39084 | 25961407 | 34 | 32050 | |||
| 2025-05-15 | 6-K | 6-K | 0001598599-25-000051 | 001-39084 | 25948324 | 34 | 30697 | |||
| 2025-05-13 | 6-K | 6-K | 0001598599-25-000049 | 001-39084 | 25936945 | 34 | 53274 | |||
| 2025-05-12 | 6-K | 6-K | 0001598599-25-000047 | 001-39084 | 25932389 | 34 | 25652 | |||
| 2025-05-07 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-045516 | 005-91173 | 25921128 | 34 | 48644 | |||
| 2025-05-06 | 6-K | 6-K | 0001598599-25-000045 | 001-39084 | 25915065 | 34 | 26020 | |||
| 2025-04-30 | 6-K | 6-K | 0001598599-25-000044 | 001-39084 | 25892388 | 34 | 23100 | |||
| 2025-04-30 | 20-F | 20-F | 0001598599-25-000042 | 001-39084 | 25891287 | 34 | 33569373 | 1 | 1 | |
| 2025-04-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-060456 | 005-91173 | 25890108 | 34 | 7902 | |||
| 2025-04-29 | 6-K | 6-K | 0001598599-25-000036 | 001-39084 | 25886249 | 34 | 30818 | |||
| 2025-04-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-059883 | 005-91173 | 25885688 | 34 | 7865 | |||
| 2025-04-28 | 6-K | 6-K | 0001598599-25-000033 | 001-39084 | 25875809 | 34 | 25137 | |||
| 2025-04-24 | 6-K | 6-K | 0001598599-25-000032 | 001-39084 | 25863417 | 34 | 58754 | |||
| 2025-04-23 | 6-K | 6-K | 0001598599-25-000030 | 001-39084 | 25859302 | 34 | 38189 | |||
| 2025-04-16 | 6-K | 6-K | 0001598599-25-000028 | 001-39084 | 25841153 | 34 | 27274 | |||
| 2025-04-16 | 6-K | 6-K | 0001598599-25-000027 | 001-39084 | 25841140 | 34 | 39205 | |||
| 2025-04-03 | 6-K | 6-K | 0001598599-25-000025 | 001-39084 | 25807314 | 34 | 23786 | |||
| 2025-03-27 | 6-K | 6-K | 0001598599-25-000023 | 001-39084 | 25775220 | 34 | 235018 | |||
| 2025-03-26 | 6-K | 6-K | 0001598599-25-000020 | 001-39084 | 25770106 | 34 | 31309 | |||
| 2025-03-25 | 6-K | 6-K | 0001598599-25-000015 | 001-39084 | 25765851 | 34 | 24338 | |||
| 2025-03-20 | 6-K | 6-K | 0001598599-25-000012 | 001-39084 | 25754488 | 34 | 26483 | |||
| 2025-02-27 | 6-K | 6-K | 0001598599-25-000009 | 001-39084 | 25672564 | 34 | 25007 | |||
| 2025-02-18 | 6-K | 6-K | 0001598599-25-000008 | 001-39084 | 25632575 | 34 | 40911 | |||
| 2025-01-27 | 6-K | 6-K | 0001598599-25-000007 | 001-39084 | 25555794 | 34 | 32347 | |||
| 2025-01-21 | 6-K | 6-K | 0001598599-25-000005 | 001-39084 | 25540232 | 34 | 27924 | |||
| 2025-01-16 | 6-K | 6-K | 0001598599-25-000004 | 001-39084 | 25534348 | 34 | 31276 | |||
| 2025-01-10 | 6-K | 6-K | 0001598599-25-000003 | 001-39084 | 25520034 | 34 | 36439 | |||
| 2024-12-20 | 6-K | 6-K | 0001598599-24-000100 | 001-39084 | 241565087 | 34 | 25794 | |||
| 2024-12-09 | 6-K | 6-K | 0001598599-24-000098 | 001-39084 | 241533700 | 34 | 40986 | |||
| 2024-12-06 | 6-K | 6-K | 0001598599-24-000095 | 001-39084 | 241530416 | 34 | 49512 | |||
| 2024-12-03 | 6-K | 6-K | 0001598599-24-000094 | 001-39084 | 241520903 | 34 | 34111 | |||
| 2024-11-20 | 6-K | 6-K | 0001598599-24-000092 | 001-39084 | 241478099 | 34 | 25748 | |||
| 2024-11-19 | 6-K | 6-K | 0001598599-24-000089 | 001-39084 | 241473232 | 34 | 31634 | |||
| 2024-11-13 | 6-K | 6-K | 0001598599-24-000086 | 001-39084 | 241450922 | 34 | 60608 | |||
| 2024-11-08 | 6-K | 6-K | 0001598599-24-000083 | 001-39084 | 241437806 | 34 | 34402 | |||
| 2024-11-07 | 6-K | 6-K | 0001598599-24-000080 | 001-39084 | 241432840 | 34 | 26683 | |||
| 2024-10-29 | 6-K | 6-K | 0001598599-24-000078 | 001-39084 | 241402654 | 34 | 28779 | |||
| 2024-10-15 | 6-K | 6-K | 0001598599-24-000077 | 001-39084 | 241369036 | 34 | 30140 | |||
| 2024-09-30 | 6-K | 6-K | 0001598599-24-000075 | 001-39084 | 241336504 | 34 | 28670 | |||
| 2024-09-23 | 6-K | 6-K | 0001598599-24-000072 | 001-39084 | 241314544 | 34 | 27494 | |||
| 2024-09-12 | 6-K | 6-K | 0001598599-24-000069 | 001-39084 | 241293830 | 34 | 205734 | |||
| 2024-09-12 | 6-K | 6-K | 0001628280-24-040187 | 001-39084 | 241293821 | 34 | 8168002 | 1 | 1 | |
| 2024-09-11 | S-8 | S-8 | 0001598599-24-000067 | 333-282031 | 241292565 | 33 | 942735 | |||
| 2024-09-09 | 6-K | 6-K | 0001598599-24-000059 | 001-39084 | 241285732 | 34 | 34544 | |||
| 2024-09-05 | 6-K | 6-K | 0001598599-24-000057 | 001-39084 | 241279770 | 34 | 26060 | |||
| 2024-09-04 | 6-K | 6-K | 0001598599-24-000054 | 001-39084 | 241275800 | 34 | 22834 | |||
| 2024-07-25 | 6-K | 6-K | 0001598599-24-000051 | 001-39084 | 241139648 | 34 | 25407 | |||
| 2024-06-18 | 6-K | 6-K | 0001598599-24-000049 | 001-39084 | 241050195 | 34 | 27423 | |||
| 2024-06-17 | 6-K | 6-K | 0001598599-24-000047 | 001-39084 | 241046859 | 34 | 33304 | |||
| 2024-06-04 | 6-K | 6-K | 0001598599-24-000044 | 001-39084 | 241015984 | 34 | 51834 | |||
| 2024-05-28 | 6-K | 6-K | 0001598599-24-000042 | 001-39084 | 24986151 | 34 | 24823 | |||
| 2024-05-24 | 6-K | 6-K | 0001598599-24-000040 | 001-39084 | 24980770 | 34 | 37125 | |||
| 2024-05-23 | 6-K | 6-K | 0001598599-24-000039 | 001-39084 | 24977991 | 34 | 23597 | |||
| 2024-05-15 | 6-K | 6-K | 0001598599-24-000036 | 001-39084 | 24946883 | 34 | 35381 | |||
| 2024-05-14 | 6-K | 6-K | 0001598599-24-000034 | 001-39084 | 24941321 | 34 | 57079 | |||
| 2024-05-07 | 6-K | 6-K | 0001598599-24-000030 | 001-39084 | 24919431 | 34 | 25588 | |||
| 2024-04-15 | 6-K | 6-K | 0001598599-24-000028 | 001-39084 | 24843033 | 34 | 32439 | |||
| 2024-04-15 | 6-K | 6-K | 0001598599-24-000026 | 001-39084 | 24843024 | 34 | 26157 | |||
| 2024-04-10 | 6-K | 6-K | 0001598599-24-000023 | 001-39084 | 24834207 | 34 | 26794 | |||
| 2024-04-04 | 20-F | 20-F | 0001598599-24-000020 | 001-39084 | 24821662 | 34 | 38148565 | 1 | 1 | |
| 2024-03-21 | 6-K | 6-K | 0001598599-24-000015 | 001-39084 | 24769728 | 34 | 175162 | |||
| 2024-03-21 | 6-K | 6-K | 0001598599-24-000013 | 001-39084 | 24769295 | 34 | 103656 | |||
| 2024-03-19 | 6-K | 6-K | 0001598599-24-000012 | 001-39084 | 24761044 | 34 | 23053 | |||
| 2024-03-14 | 6-K | 6-K | 0001598599-24-000010 | 001-39084 | 24747882 | 34 | 26495 | |||
| 2024-03-06 | 6-K | 6-K | 0001598599-24-000007 | 001-39084 | 24724279 | 34 | 35398 | |||
| 2024-03-06 | 6-K | 6-K | 0001598599-24-000006 | 001-39084 | 24724277 | 34 | 28994 | |||
| 2024-02-21 | 6-K | 6-K | 0001598599-24-000002 | 001-39084 | 24656266 | 34 | 23380 | |||
| 2024-02-06 | 6-K | 6-K | 0001628280-24-003515 | 001-39084 | 24601102 | 34 | 440854 | |||
| 2024-02-06 | 424B5 | 424B5 | 0001628280-24-003513 | 333-276164 | 24601051 | 33 | 1091548 | |||
| 2024-01-16 | EFFECT | xslEFFECTX01/primary_doc.xml | F-3,,2024-01-16 16:30:00 | 9999999995-24-000128 | 333-276164 | 24536630 | 33 | 1860 | ||
| 2024-01-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000054 | 001-39084 | 24530493 | 34 | 20367 | |||
| 2024-01-11 | CORRESP | filename1.htm | 0001628280-24-001123 | 11075 | ||||||
| 2024-01-05 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000024 | 001-39084 | 24514387 | 34 | 14096 | |||
| 2024-01-04 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-24-000013 | 001-39084 | 24509685 | 34 | 22769 | |||
| 2024-01-04 | 6-K | INNATE PHARMA 6-K | 0001157523-24-000012 | 001-39084 | 24509683 | 34 | 21739 | |||
| 2023-12-26 | UPLOAD | filename1.pdf | 0000000000-23-014072 | 333-276164 | 40406 | |||||
| 2023-12-20 | F-3 | F-3 | 0001628280-23-042262 | 333-276164 | 231501842 | 33 | 909613 | |||
| 2023-12-20 | 6-K | 6-K | 0001628280-23-042242 | 001-39084 | 231501662 | 34 | 339349 | |||
| 2023-12-19 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001840 | 001-39084 | 231495522 | 34 | 25030 | |||
| 2023-12-18 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001834 | 001-39084 | 231492681 | 34 | 21143 | |||
| 2023-12-11 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001813 | 001-39084 | 231476826 | 34 | 44051 | |||
| 2023-12-11 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001812 | 001-39084 | 231476820 | 34 | 25640 | |||
| 2023-11-27 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001768 | 001-39084 | 231437237 | 34 | 26290 | |||
| 2023-11-14 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001721 | 001-39084 | 231401275 | 34 | 41702 | |||
| 2023-11-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001658 | 001-39084 | 231381355 | 34 | 19963 | |||
| 2023-11-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001642 | 001-39084 | 231374366 | 34 | 27888 | |||
| 2023-10-27 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001561 | 001-39084 | 231351816 | 34 | 17413 | |||
| 2023-10-19 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001503 | 001-39084 | 231333282 | 34 | 17331 | |||
| 2023-10-16 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001483 | 001-39084 | 231326123 | 34 | 23207 | |||
| 2023-10-10 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001465 | 001-39084 | 231315331 | 34 | 21236 | |||
| 2023-10-05 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001462 | 001-39084 | 231309734 | 34 | 25330 | |||
| 2023-09-22 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001438 | 001-39084 | 231270176 | 34 | 46447 | |||
| 2023-09-14 | 6-K | 6-K | 0001628280-23-032230 | 001-39084 | 231254000 | 34 | 9142796 | 1 | 1 | |
| 2023-09-14 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001412 | 001-39084 | 231253963 | 34 | 273387 | |||
| 2023-08-29 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001371 | 001-39084 | 231217936 | 34 | 20245 | |||
| 2023-08-10 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001311 | 001-39084 | 231157018 | 34 | 17659 | |||
| 2023-07-11 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001074 | 001-39084 | 231081144 | 34 | 23473 | |||
| 2023-07-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001068 | 001-39084 | 231075124 | 34 | 23766 | |||
| 2023-06-26 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-001026 | 001-39084 | 231039331 | 34 | 23905 | |||
| 2023-06-16 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000977 | 001-39084 | 231019260 | 34 | 36154 | |||
| 2023-06-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000961 | 001-39084 | 231007014 | 34 | 26240 | |||
| 2023-06-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000960 | 001-39084 | 231007008 | 34 | 23232 | |||
| 2023-06-08 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000948 | 001-39084 | 231000575 | 34 | 24292 | |||
| 2023-06-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000944 | 001-39084 | 23997575 | 34 | 22194 | |||
| 2023-05-26 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000914 | 001-39084 | 23962856 | 34 | 23655 | |||
| 2023-05-23 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000901 | 001-39084 | 23946429 | 34 | 23010 | |||
| 2023-05-15 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000838 | 001-39084 | 23918075 | 34 | 23983 | |||
| 2023-05-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000829 | 001-39084 | 23915404 | 34 | 18112 | |||
| 2023-05-10 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000793 | 001-39084 | 23904148 | 34 | 36502 | |||
| 2023-05-09 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000776 | 001-39084 | 23899748 | 34 | 23921 | |||
| 2023-05-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000690 | 001-39084 | 23881497 | 34 | 18847 | |||
| 2023-05-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000689 | 001-39084 | 23881493 | 34 | 27542 | |||
| 2023-04-26 | 6-K | 6-K | 0001628280-23-013218 | 001-39084 | 23849651 | 34 | 37994 | |||
| 2023-04-26 | 6-K | 6-K | 0001628280-23-013216 | 001-39084 | 23849636 | 34 | 474378 | |||
| 2023-04-26 | 424B5 | 424B5 | 0001628280-23-013213 | 333-252074 | 23849614 | 33 | 1692015 | |||
| 2023-04-21 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000592 | 001-39084 | 23834397 | 34 | 17935 | |||
| 2023-04-20 | 20-F/A | 20-F/A | 0001628280-23-012160 | 001-39084 | 23831498 | 34 | 19911679 | 1 | 1 | |
| 2023-04-18 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000565 | 001-39084 | 23825404 | 34 | 24149 | |||
| 2023-04-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000530 | 001-39084 | 23807715 | 34 | 18699 | |||
| 2023-04-06 | 20-F | 20-F | 0001628280-23-010946 | 001-39084 | 23804346 | 34 | 33627728 | 1 | 1 | |
| 2023-04-06 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000525 | 001-39084 | 23804296 | 34 | 19623 | |||
| 2023-04-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000507 | 001-39084 | 23790268 | 34 | 21928 | |||
| 2023-03-23 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000478 | 001-39084 | 23754339 | 34 | 288096 | |||
| 2023-03-20 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000462 | 001-39084 | 23744822 | 34 | 23733 | |||
| 2023-03-16 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000443 | 001-39084 | 23737010 | 34 | 18387 | |||
| 2023-03-13 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000424 | 001-39084 | 23725531 | 34 | 19755 | |||
| 2023-02-21 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000305 | 001-39084 | 23645108 | 34 | 25061 | |||
| 2023-02-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000179 | 001-39084 | 23592636 | 34 | 18171 | |||
| 2023-01-25 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000082 | 001-39084 | 23549623 | 34 | 20436 | |||
| 2023-01-17 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-23-000047 | 001-39084 | 23530042 | 34 | 22850 | |||
| 2022-12-19 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001754 | 001-39084 | 221469520 | 34 | 29325 | |||
| 2022-12-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001731 | 001-39084 | 221456055 | 34 | 23515 | |||
| 2022-12-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001730 | 001-39084 | 221456049 | 34 | 36887 | |||
| 2022-12-09 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001718 | 001-39084 | 221453590 | 34 | 20764 | |||
| 2022-12-06 | SC 13D/A | SC 13D/A | 0001104659-22-124799 | 005-91173 | 221447071 | 34 | 127016 | |||
| 2022-12-01 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001695 | 001-39084 | 221437174 | 34 | 23376 | |||
| 2022-11-14 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001601 | 001-39084 | 221379582 | 34 | 32644 | |||
| 2022-11-07 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001535 | 001-39084 | 221363550 | 34 | 18932 | |||
| 2022-11-04 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001530 | 001-39084 | 221360022 | 34 | 24475 | |||
| 2022-11-02 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001469 | 001-39084 | 221352147 | 34 | 21952 | |||
| 2022-10-21 | SC 13D/A | SC 13D/A | 0001104659-22-110519 | 005-91173 | 221322921 | 34 | 111882 | |||
| 2022-10-20 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001344 | 001-39084 | 221319673 | 34 | 22245 | |||
| 2022-09-23 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001257 | 001-39084 | 221260523 | 34 | 38353 | |||
| 2022-09-15 | 6-K | 6-K | 0001628280-22-024942 | 001-39084 | 221244439 | 34 | 9854221 | 1 | 1 | |
| 2022-09-08 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001192 | 001-39084 | 221232451 | 34 | 19313 | |||
| 2022-09-06 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001182 | 001-39084 | 221226727 | 34 | 28501 | |||
| 2022-08-23 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001151 | 001-39084 | 221185015 | 34 | 19304 | |||
| 2022-08-17 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-001128 | 001-39084 | 221172023 | 34 | 19507 | |||
| 2022-08-01 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000965 | 001-39084 | 221122636 | 34 | 26443 | |||
| 2022-07-28 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000940 | 001-39084 | 221112589 | 34 | 18051 | |||
| 2022-07-21 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000880 | 001-39084 | 221095487 | 34 | 24017 | |||
| 2022-06-23 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000792 | 001-39084 | 221033485 | 34 | 19205 | |||
| 2022-06-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000721 | 001-39084 | 22992834 | 34 | 22141 | |||
| 2022-05-20 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000671 | 001-39084 | 22947660 | 34 | 22907 | |||
| 2022-05-11 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000609 | 001-39084 | 22911912 | 34 | 18351 | |||
| 2022-05-10 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000595 | 001-39084 | 22907207 | 34 | 24124 | |||
| 2022-05-10 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000594 | 001-39084 | 22907201 | 34 | 35941 | |||
| 2022-05-04 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000548 | 001-39084 | 22888573 | 34 | 26836 | |||
| 2022-05-03 | 6-K | 6-K | 0001628280-22-012036 | 001-39084 | 22888187 | 34 | 491084 | |||
| 2022-05-03 | 424B5 | 424B5 | 0001628280-22-012012 | 333-252074 | 22887619 | 33 | 1546474 | |||
| 2022-05-03 | 6-K | 6-K | 0001628280-22-012010 | 001-39084 | 22887590 | 34 | 6682161 | |||
| 2022-05-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000532 | 001-39084 | 22884442 | 34 | 20778 | |||
| 2022-04-29 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000507 | 001-39084 | 22869790 | 34 | 28930 | |||
| 2022-04-08 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000404 | 001-39084 | 22815285 | 34 | 19010 | |||
| 2022-04-05 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000390 | 001-39084 | 22805090 | 34 | 18246 | |||
| 2022-04-04 | 20-F | 20-F | 0001628280-22-008197 | 001-39084 | 22800329 | 34 | 64356146 | 1 | 1 | |
| 2022-03-24 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000362 | 001-39084 | 22764598 | 34 | 198660 | |||
| 2022-03-17 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000339 | 001-39084 | 22746604 | 34 | 18761 | |||
| 2022-03-03 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000281 | 001-39084 | 22706634 | 34 | 22343 | |||
| 2022-02-15 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000201 | 001-39084 | 22636923 | 34 | 22594 | |||
| 2022-02-04 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000148 | 001-39084 | 22590771 | 34 | 18801 | |||
| 2022-01-24 | 6-K | INNATE PHARMA S.A. FORM 6-K | 0001157523-22-000080 | 001-39084 | 22547349 | 34 | 24224 | |||
| 2022-01-05 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000023 | 001-39084 | 22509306 | 34 | 19102 | |||
| 2022-01-04 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-22-000004 | 001-39084 | 22503963 | 34 | 18169 | |||
| 2021-12-16 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001502 | 001-39084 | 211495891 | 34 | 25116 | |||
| 2021-12-09 | 6-K | INNATE PHARMA S.A. FORM 6-K | 0001157523-21-001489 | 001-39084 | 211480186 | 34 | 25944 | |||
| 2021-12-02 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001468 | 001-39084 | 211464880 | 34 | 24259 | |||
| 2021-11-24 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001447 | 001-39084 | 211441240 | 34 | 18004 | |||
| 2021-11-16 | 6-K | INNATE PHARMA S.A. FORM 6-K | 0001157523-21-001418 | 001-39084 | 211413946 | 34 | 32749 | |||
| 2021-11-12 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001396 | 001-39084 | 211399440 | 34 | 27141 | |||
| 2021-11-09 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001372 | 001-39084 | 211389778 | 34 | 19223 | |||
| 2021-10-26 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001251 | 001-39084 | 211345818 | 34 | 22124 | |||
| 2021-10-15 | 6-K | INNATE PHARMA S.A. 6-K | 0001157523-21-001203 | 001-39084 | 211324704 | 34 | 20467 | |||
| 2021-09-23 | 6-K | FORM 6-K | 0001171843-21-006617 | 001-39084 | 211270971 | 34 | 13900 | |||
| 2021-09-17 | 6-K | FORM 6-K | 0001171843-21-006518 | 001-39084 | 211259247 | 34 | 17062 | |||
| 2021-09-15 | 6-K | 6-K | 0001628280-21-018642 | 001-39084 | 211254159 | 34 | 8928848 | 1 | 1 | |
| 2021-09-07 | 6-K | FORM 6-K | 0001171843-21-006330 | 001-39084 | 211238207 | 34 | 12725 | |||
| 2021-09-02 | 6-K | FORM 6-K | 0001171843-21-006274 | 001-39084 | 211231675 | 34 | 17605 | |||
| 2021-08-30 | 6-K | FORM 6-K | 0001171843-21-006213 | 001-39084 | 211220824 | 34 | 11817 | |||
| 2021-08-11 | 6-K | FORM 6-K | 0001171843-21-005800 | 001-39084 | 211161895 | 34 | 16109 | |||
| 2021-07-12 | S-8 | S-8 | 0001628280-21-013747 | 333-257834 | 211085216 | 33 | 934272 | |||
| 2021-07-12 | 6-K | FORM 6-K | 0001171843-21-004826 | 001-39084 | 211084220 | 34 | 14105 | |||
| 2021-07-06 | 6-K | FORM 6-K | 0001171843-21-004701 | 001-39084 | 211072433 | 34 | 17209 | |||
| 2021-06-22 | 6-K | FORM 6-K | 0001171843-21-004461 | 001-39084 | 211033019 | 34 | 19677 | |||
| 2021-06-16 | 6-K | FORM 6-K | 0001171843-21-004364 | 001-39084 | 211020458 | 34 | 17862 | |||
| 2021-06-14 | 6-K | FORM 6-K | 0001171843-21-004300 | 001-39084 | 211013265 | 34 | 15123 | |||
| 2021-06-10 | 6-K | FORM 6-K | 0001171843-21-004266 | 001-39084 | 211006854 | 34 | 17003 | |||
| 2021-06-09 | 6-K | FORM 6-K | 0001171843-21-004237 | 001-39084 | 211003932 | 34 | 16410 | |||
| 2021-05-28 | 6-K | FORM 6-K | 0001171843-21-003883 | 001-39084 | 21980047 | 34 | 14078 | |||
| 2021-05-25 | 6-K | FORM 6-K | 0001171843-21-003747 | 001-39084 | 21957305 | 34 | 14461 | |||
| 2021-05-12 | 6-K | FORM 6-K | 0001171843-21-003405 | 001-39084 | 21913390 | 34 | 14863 | |||
| 2021-05-11 | 6-K | FORM 6-K | 0001171843-21-003363 | 001-39084 | 21909538 | 34 | 19026 | |||
| 2021-05-04 | 6-K | FORM 6-K | 0001171843-21-003078 | 001-39084 | 21885851 | 34 | 12493 | |||
| 2021-04-28 | 6-K | FORM 6-K | 0001171843-21-002830 | 001-39084 | 21861234 | 34 | 12215 | |||
| 2021-04-27 | 20-F | 20-F | 0001628280-21-007629 | 001-39084 | 21855784 | 34 | 32902310 | 1 | 1 | |
| 2021-04-21 | 6-K | FORM 6-K | 0001171843-21-002589 | 001-39084 | 21839542 | 34 | 14341 | |||
| 2021-04-21 | 6-K | FORM 6-K | 0001171843-21-002588 | 001-39084 | 21839541 | 34 | 174189 | |||
| 2021-04-19 | 6-K | FORM 6-K | 0001171843-21-002537 | 001-39084 | 21833128 | 34 | 14218 | |||
| 2021-03-18 | 6-K | FORM 6-K | 0001171843-21-001882 | 001-39084 | 21753028 | 34 | 100409 | |||
| 2021-03-16 | 6-K | FORM 6-K | 0001171843-21-001808 | 001-39084 | 21743578 | 34 | 12538 | |||
| 2021-02-24 | 6-K | FORM 6-K | 0001171843-21-001251 | 001-39084 | 21668414 | 34 | 14101 | |||
| 2021-02-17 | 6-K | FORM 6-K | 0001171843-21-001075 | 001-39084 | 21642584 | 34 | 12319 | |||
| 2021-02-12 | SC 13D | SC 13D | 0001104659-21-021713 | 005-91173 | 21625864 | 34 | 126663 | |||
| 2021-02-09 | 6-K | FORM 6-K | 0001171843-21-000847 | 001-39084 | 21603868 | 34 | 21172 | |||
| 2021-02-04 | 6-K | FORM 6-K | 0001171843-21-000737 | 001-39084 | 21589000 | 34 | 15122 | |||
| 2021-01-28 | EFFECT | xslEFFECTX01/primary_doc.xml | F-3,,2021-01-28 17:00:00 | 9999999995-21-000330 | 333-252074 | 21567872 | 33 | 1811 | ||
| 2021-01-27 | CORRESP | filename1.htm | 0001628280-21-000831 | 21445 | ||||||
| 2021-01-19 | UPLOAD | filename1.pdf | 0000000000-21-000649 | 40279 | ||||||
| 2021-01-13 | F-3 | F-3 | 0001628280-21-000427 | 333-252074 | 21525785 | 33 | 1282521 | |||
| 2021-01-05 | 6-K | FORM 6-K | 0001171843-21-000035 | 001-39084 | 21503866 | 34 | 15534 | |||
| 2021-01-04 | 6-K | FORM 6-K | 0001171843-21-000004 | 001-39084 | 21500108 | 34 | 12175 | |||
| 2020-12-11 | 6-K | FORM 6-K | 0001171843-20-008510 | 001-39084 | 201382217 | 34 | 18999 | |||
| 2020-12-03 | 6-K | FORM 6-K | 0001171843-20-008318 | 001-39084 | 201365807 | 34 | 17044 | |||
| 2020-12-02 | 6-K | FORM 6-K | 0001171843-20-008269 | 001-39084 | 201362360 | 34 | 13332 | |||
| 2020-11-17 | 6-K | FORM 6-K | 0001171843-20-008059 | 001-39084 | 201319218 | 34 | 19376 | |||
| 2020-11-13 | 6-K | FORM 6-K | 0001171843-20-007954 | 001-39084 | 201309098 | 34 | 16557 | |||
| 2020-11-12 | 6-K | FORM 6-K | 0001171843-20-007890 | 001-39084 | 201303156 | 34 | 12770 | |||
| 2020-11-05 | 6-K | FORM 6-K | 0001171843-20-007634 | 001-39084 | 201288757 | 34 | 14432 | |||
| 2020-10-23 | 6-K | FORM 6-K | 0001171843-20-007194 | 001-39084 | 201255995 | 34 | 18113 | |||
| 2020-10-13 | 6-K | FORM 6-K | 0001171843-20-007004 | 001-39084 | 201234481 | 34 | 14999 | |||
| 2020-09-08 | 6-K | FORM 6-K | 0001171843-20-006299 | 001-39084 | 201162889 | 34 | 844725 | |||
| 2020-08-12 | 6-K | FORM 6-K | 0001171843-20-005838 | 001-39084 | 201094027 | 34 | 14278 | |||
| 2020-08-11 | 6-K | FORM 6-K | 0001171843-20-005816 | 001-39084 | 201092195 | 34 | 18516 | |||
| 2020-07-29 | 6-K | FORM 6-K | 0001171843-20-005318 | 001-39084 | 201055659 | 34 | 16498 | |||
| 2020-07-16 | 6-K | FORM 6-K | 0001171843-20-004976 | 001-39084 | 201030722 | 34 | 15896 | |||
| 2020-06-24 | 6-K | FORM 6-K | 0001171843-20-004510 | 001-39084 | 20983756 | 34 | 21083 | |||
| 2020-05-20 | 6-K | FORM 6-K | 0001171843-20-003852 | 001-39084 | 20895661 | 34 | 11667 | |||
| 2020-05-14 | 6-K | FORM 6-K | 0001171843-20-003689 | 001-39084 | 20875216 | 34 | 19866 | |||
| 2020-05-12 | 6-K | FORM 6-K | 0001171843-20-003611 | 001-39084 | 20866989 | 34 | 19859 | |||
| 2020-05-06 | 6-K | FORM 6-K | 0001171843-20-003351 | 001-39084 | 20851033 | 34 | 14253 | |||
| 2020-04-28 | 6-K | FORM 6-K | 0001171843-20-002932 | 001-39084 | 20822222 | 34 | 15875 | |||
| 2020-04-24 | 20-F | FORM 20-F | 0001171843-20-002847 | 001-39084 | 20813173 | 34 | 17913347 | 1 | ||
| 2020-04-24 | 6-K | FORM 6-K | 0001171843-20-002845 | 001-39084 | 20813143 | 34 | 10551 | |||
| 2020-04-17 | 6-K | FORM 6-K | 0001171843-20-002678 | 001-39084 | 20797824 | 34 | 234110 | |||
| 2020-04-14 | 6-K | FORM 6-K | 0001171843-20-002598 | 001-39084 | 20790119 | 34 | 234888 | |||
| 2020-04-14 | 6-K | FORM 6-K | 0001171843-20-002592 | 001-39084 | 20790017 | 34 | 12525 | |||
| 2020-03-10 | 6-K | FORM 6-K | 0001171843-20-001582 | 001-39084 | 20699874 | 34 | 15611 | |||
| 2020-03-10 | 6-K | FORM 6-K | 0001171843-20-001581 | 001-39084 | 20699873 | 34 | 96594 | |||
| 2020-02-03 | SC 13G | FORM SC 13G | 0000950103-20-001698 | 005-91173 | 20566945 | 34 | 48172 | |||
| 2020-01-14 | 6-K | FORM 6-K | 0001171843-20-000216 | 001-39084 | 20524932 | 34 | 18729 | |||
| 2020-01-09 | 6-K | FORM 6-K | 0001171843-20-000124 | 001-39084 | 20516990 | 34 | 17149 | |||
| 2020-01-02 | 6-K | FORM 6-K | 0001171843-20-000005 | 001-39084 | 20500051 | 34 | 15387 | |||
| 2019-12-13 | 6-K | FORM 6-K | 0001171843-19-008091 | 001-39084 | 191283345 | 34 | 19993 | |||
| 2019-12-09 | 6-K | FORM 6-K | 0001171843-19-008007 | 001-39084 | 191274262 | 34 | 24773 | |||
| 2019-12-06 | 6-K | FORM 6-K | 0001171843-19-007999 | 001-39084 | 191273384 | 34 | 37448 | |||
| 2019-10-25 | SC 13D | SC 13D | 0001104659-19-056493 | 005-91173 | 191169378 | 34 | 226431 | |||
| 2019-10-23 | SC 13G | innate13g.htm | 0000935836-19-000556 | 005-91173 | 191163868 | 34 | 47193 | |||
| 2019-10-18 | 424B4 | 424B4 | 0001193125-19-270053 | 333-233865 | 191157834 | 33 | 6270702 | |||
| 2019-10-17 | FWP | FWP (PRESS RELEASE) | 0001193125-19-268845 | 333-233865 | 191153971 | 34 | 89829 | |||
| 2019-10-17 | FWP | FWP | 0001193125-19-268841 | 333-233865 | 191153967 | 34 | 10657 | |||
| 2019-10-17 | POS EX | POS EX | 0001193125-19-268738 | 333-233865 | 191153814 | 33 | 77993 | |||
| 2019-10-16 | EFFECT | xslEFFECTX01/primary_doc.xml | F-6,,2019-10-16 16:30:00 | 9999999995-19-002357 | 333-234063 | 191160492 | 33 | 1812 | ||
| 2019-10-16 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2019-10-16 17:00:00 | 9999999995-19-002325 | 333-233865 | 191153834 | 33 | 1812 | ||
| 2019-10-16 | CERT | 8A CERT | 0001354457-19-000527 | 001-39084 | 191152097 | 34 | 86953 | |||
| 2019-10-11 | CORRESP | filename1.htm | 0001193125-19-266743 | 18807 | ||||||
| 2019-10-11 | CORRESP | filename1.htm | 0001193125-19-266732 | 14819 | ||||||
| 2019-10-10 | 8-A12B | 8-A12B | 0001193125-19-265818 | 001-39084 | 191146256 | 34 | 16011 | |||
| 2019-10-09 | F-6/A | e619113_f6a-innate.htm | 0001193805-19-001209 | 333-234063 | 191144865 | 33 | 512244 | |||
| 2019-10-04 | F-1/A | F-1/A | 0001193125-19-262824 | 333-233865 | 191139075 | 33 | 7091445 | |||
| 2019-10-03 | F-6 | e618685_f6-innate.htm | 0001193805-19-000894 | 333-234063 | 191134658 | 33 | 544315 | |||
| 2019-10-01 | SEC STAFF LETTER | filename1.pdf | 9999999997-19-007193 | 141223 | ||||||
| 2019-09-20 | F-1 | F-1 | 0001193125-19-250682 | 333-233865 | 191104787 | 33 | 10357232 | |||
| 2019-09-05 | SEC STAFF LETTER | filename1.pdf | 9999999997-19-006702 | 147400 | ||||||
| 2019-08-30 | DRSLTR | filename1.htm | 0000950123-19-008751 | 58003 | ||||||
| 2019-08-30 | DRS/A | filename1.htm | 0000950123-19-008748 | 377-02690 | 191070174 | 33 | 8830833 | |||
| 2019-07-30 | UPLOAD | filename1.pdf | 0000000000-19-011750 | 50974 | ||||||
| 2019-07-19 | DRSLTR | filename1.htm | 0000950123-19-006513 | 70750 | ||||||
| 2019-07-19 | DRS/A | filename1.htm | 0000950123-19-006509 | 377-02690 | 19964153 | 33 | 5460776 | |||
| 2019-07-03 | UPLOAD | filename1.pdf | 0000000000-19-010756 | 55415 | ||||||
| 2019-06-10 | DRS | filename1.htm | 0000950123-19-005898 | 377-02690 | 19887431 | 33 | 6369470 | |||
| 2014-01-31 | D | xslFormDX01/primary_doc.xml | 06b | 0001598599-14-000001 | 021-211065 | 14563677 | 33 | 6735 |
One latest value per concept from companyfacts (226 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 93.72M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | AccountingProfit | AccountingProfit | EUR | -49.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | AcquisitionsThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment | EUR | 285,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets | AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | 644,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdditionsToRightofuseAssets | AdditionsToRightofuseAssets | EUR | 1.20M | 2020-01-01 | 2020-01-31 | 2020 | FY | 20-F | 2021-04-27 | 0001628280-21-007629 |
| ifrs-full | AdjustedWeightedAverageShares | AdjustedWeightedAverageShares | shares | 86.94M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets | AdjustmentsForDecreaseIncreaseInAccruedIncomeIncludingContractAssets | EUR | -352,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | AdjustmentsForDecreaseIncreaseInTradeAndOtherReceivables | EUR | 1.65M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForDepreciationAndAmortisationExpense | AdjustmentsForDepreciationAndAmortisationExpense | EUR | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForFairValueGainsLosses | AdjustmentsForFairValueGainsLosses | EUR | -451,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForFinanceCosts | AdjustmentsForFinanceCosts | EUR | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-04 | 0001598599-24-000020 |
| ifrs-full | AdjustmentsForFinanceIncome | AdjustmentsForFinanceIncome | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment | AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment | EUR | -23,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInDeferredIncome | AdjustmentsForIncreaseDecreaseInDeferredIncome | EUR | -5.91M | 2021-01-01 | 2021-06-30 | 2021 | Q2 | 6-K | 2021-09-15 | 0001628280-21-018642 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities | AdjustmentsForIncreaseDecreaseInDeferredIncomeIncludingContractLiabilities | EUR | -616,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities | AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities | EUR | -807,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | AdjustmentsForIncreaseDecreaseInTradeAndOtherPayables | EUR | -965,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForProvisions | AdjustmentsForProvisions | EUR | 3.33M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForSharebasedPayments | AdjustmentsForSharebasedPayments | EUR | 2.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AdjustmentsForUnrealisedForeignExchangeLossesGains | AdjustmentsForUnrealisedForeignExchangeLossesGains | EUR | 1.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AmortisationIntangibleAssetsOtherThanGoodwill | AmortisationIntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AmountsPayableRelatedPartyTransactions | AmountsPayableRelatedPartyTransactions | EUR | 1.57M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | AmountsReceivableRelatedPartyTransactions | AmountsReceivableRelatedPartyTransactions | EUR | 565,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ApplicableTaxRate | ApplicableTaxRate | pure | 0.25 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | Assets | Assets | EUR | 62.72M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | AuditorsRemuneration | AuditorsRemuneration | EUR | 1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AuditorsRemunerationForAuditServices | AuditorsRemunerationForAuditServices | EUR | 1.03M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AuditorsRemunerationForOtherServices | AuditorsRemunerationForOtherServices | EUR | 260,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AverageEffectiveTaxRate | AverageEffectiveTaxRate | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | AverageForeignExchangeRate | AverageForeignExchangeRate | USD/EUR | 1.13 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | AverageNumberOfEmployees | AverageNumberOfEmployees | employee | 170 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | BankBorrowingsUndiscountedCashFlows | BankBorrowingsUndiscountedCashFlows | EUR | 23.26M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | BasicEarningsLossPerShare | BasicEarningsLossPerShare | EUR/shares | -0.55 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | BasicEarningsLossPerShareFromContinuingOperations | BasicEarningsLossPerShareFromContinuingOperations | EUR/shares | -0.55 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | BasicEarningsLossPerShareFromDiscontinuedOperations | BasicEarningsLossPerShareFromDiscontinuedOperations | EUR/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashAdvancesAndLoansFromRelatedParties | CashAdvancesAndLoansFromRelatedParties | EUR | 2.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashAdvancesAndLoansMadeToRelatedParties | CashAdvancesAndLoansMadeToRelatedParties | EUR | 4.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | EUR | 28.09M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CashFlowsFromUsedInFinancingActivities | CashFlowsFromUsedInFinancingActivities | EUR | 6.07M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations | CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | CashFlowsFromUsedInInvestingActivities | CashFlowsFromUsedInInvestingActivities | EUR | 7.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations | CashFlowsFromUsedInInvestingActivitiesDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | CashFlowsFromUsedInOperatingActivities | CashFlowsFromUsedInOperatingActivities | EUR | -52.76M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations | CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital | EUR | -42.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties | CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToRelatedParties | EUR | 17.52M | 2020-01-01 | 2020-12-31 | 2020 | FY | 20-F | 2021-04-27 | 0001628280-21-007629 |
| ifrs-full | CashRepaymentsOfAdvancesAndLoansFromRelatedParties | CashRepaymentsOfAdvancesAndLoansFromRelatedParties | EUR | 2.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ClosingForeignExchangeRate | ClosingForeignExchangeRate | USD/EUR | 1.175 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ComprehensiveIncome | ComprehensiveIncome | EUR | -48.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset | ContributionsToPlanByEmployerNetDefinedBenefitLiabilityAsset | EUR | 216,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | CurrentAdvancesToSuppliers | CurrentAdvancesToSuppliers | EUR | 2.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentAssets | CurrentAssets | EUR | 46.71M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentDeferredIncomeIncludingCurrentContractLiabilities | CurrentDeferredIncomeIncludingCurrentContractLiabilities | EUR | 2.83M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentFinancialAssets | CurrentFinancialAssets | EUR | 6.22M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentFinancialLiabilities | CurrentFinancialLiabilities | EUR | 8.80M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentInvestments | CurrentInvestments | EUR | 6.22M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentLiabilities | CurrentLiabilities | EUR | 36.65M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | CurrentPayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | EUR | 400,000 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 | |
| ifrs-full | CurrentPrepaidExpenses | CurrentPrepaidExpenses | EUR | 2.39M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentProvisions | CurrentProvisions | EUR | 3.48M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentReceivablesFromTaxesOtherThanIncomeTax | CurrentReceivablesFromTaxesOtherThanIncomeTax | USD | 16.74M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | CurrentServiceCostNetDefinedBenefitLiabilityAsset | CurrentServiceCostNetDefinedBenefitLiabilityAsset | EUR | 166,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | CurrentTaxExpenseIncome | CurrentTaxExpenseIncome | EUR | 0 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods | CurrentTaxExpenseIncomeAndAdjustmentsForCurrentTaxOfPriorPeriods | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | CurrentTradeReceivables | CurrentTradeReceivables | EUR | 391,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | CurrentValueAddedTaxReceivables | CurrentValueAddedTaxReceivables | EUR | 909,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | DeferredIncome | DeferredIncome | EUR | 38.07M | 2021-06-30 | 2021 | Q2 | 6-K | 2021-09-15 | 0001628280-21-018642 | |
| ifrs-full | DeferredIncomeClassifiedAsCurrent | DeferredIncomeClassifiedAsCurrent | EUR | 10.46M | 2021-06-30 | 2021 | Q2 | 6-K | 2021-09-15 | 0001628280-21-018642 | |
| ifrs-full | DeferredIncomeClassifiedAsNoncurrent | DeferredIncomeClassifiedAsNoncurrent | EUR | 27.60M | 2021-06-30 | 2021 | Q2 | 6-K | 2021-09-15 | 0001628280-21-018642 | |
| ifrs-full | DeferredIncomeIncludingContractLiabilities | DeferredIncomeIncludingContractLiabilities | EUR | 2.83M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | DeferredTaxAssets | DeferredTaxAssets | EUR | 9.12M | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 | |
| ifrs-full | DeferredTaxExpenseIncome | DeferredTaxExpenseIncome | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DeferredTaxLiabilities | DeferredTaxLiabilities | EUR | 9.12M | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 | |
| ifrs-full | DefinedBenefitObligationAtPresentValue | DefinedBenefitObligationAtPresentValue | EUR | 1.92M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | DepreciationAndAmortisationExpense | DepreciationAndAmortisationExpense | EUR | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DepreciationPropertyPlantAndEquipment | DepreciationPropertyPlantAndEquipment | EUR | 845,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets | DepreciationPropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | 1.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DilutedEarningsLossPerShare | DilutedEarningsLossPerShare | EUR/shares | -0.55 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DilutedEarningsLossPerShareFromContinuingOperations | DilutedEarningsLossPerShareFromContinuingOperations | EUR/shares | -0.55 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DilutedEarningsLossPerShareFromDiscontinuedOperations | DilutedEarningsLossPerShareFromDiscontinuedOperations | EUR/shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares | DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares | shares | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DiscountedUnguaranteedResidualValueOfAssetsSubjectToFinanceLease | DiscountedUnguaranteedResidualValueOfAssetsSubjectToFinanceLease | EUR | 46,000 | 2018-12-31 | 2021 | FY | 20-F | 2022-04-04 | 0001628280-22-008197 | |
| ifrs-full | DisposalsIntangibleAssetsOtherThanGoodwill | DisposalsIntangibleAssetsOtherThanGoodwill | EUR | 41.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | DisposalsPropertyPlantAndEquipment | DisposalsPropertyPlantAndEquipment | EUR | 18,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets | DisposalsPropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | 23,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | EffectOfExchangeRateChangesOnCashAndCashEquivalents | EffectOfExchangeRateChangesOnCashAndCashEquivalents | EUR | 1.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | EmployeeBenefitsExpense | EmployeeBenefitsExpense | EUR | 27.36M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | Equity | Equity | EUR | -21.70M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | EquityAndLiabilities | EquityAndLiabilities | EUR | 62.72M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsWithEmployees | ExpenseFromSharebasedPaymentTransactionsWithEmployees | EUR | 2.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ExpenseOfRestructuringActivities | ExpenseOfRestructuringActivities | EUR | 2.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | FinanceCosts | FinanceCosts | EUR | 3.12M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | FinanceIncome | FinanceIncome | EUR | 7.95M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | FinanceIncomeCost | FinanceIncomeCost | EUR | 4.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | FinancialAssets | FinancialAssets | EUR | 57.42M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | FinancialAssetsAtFairValue | FinancialAssetsAtFairValue | EUR | 57.42M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | FinancialLiabilities | FinancialLiabilities | EUR | 22.57M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ForeignExchangeGain | ForeignExchangeGain | EUR | 5.63M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | ForeignExchangeLoss | ForeignExchangeLoss | EUR | 2.57M | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset | GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset | EUR | 94,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | GainsLossesOnDisposalsOfPropertyPlantAndEquipment | GainsLossesOnDisposalsOfPropertyPlantAndEquipment | EUR | -18,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | GeneralAndAdministrativeExpense | GeneralAndAdministrativeExpense | EUR | 19.39M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ImpairmentLossRecognisedInProfitOrLossTradeReceivables | ImpairmentLossRecognisedInProfitOrLossTradeReceivables | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncomeTaxesPaidRefundClassifiedAsOperatingActivities | IncomeTaxesPaidRefundClassifiedAsOperatingActivities | EUR | -6.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncomeTaxExpenseContinuingOperations | IncomeTaxExpenseContinuingOperations | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalents | IncreaseDecreaseInCashAndCashEquivalents | EUR | -38.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations | IncreaseDecreaseInCashAndCashEquivalentsDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges | IncreaseDecreaseInNetDefinedBenefitLiabilityAssetResultingFromMiscellaneousOtherChanges | EUR | -851,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseInNumberOfOrdinarySharesIssued | IncreaseDecreaseInNumberOfOrdinarySharesIssued | shares | 14.38M | 2019-01-01 | 2019-12-31 | 2021 | FY | 20-F | 2022-04-04 | 0001628280-22-008197 |
| ifrs-full | IncreaseDecreaseInWorkingCapital | IncreaseDecreaseInWorkingCapital | EUR | 10.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughAppropriationOfRetainedEarnings | IncreaseDecreaseThroughAppropriationOfRetainedEarnings | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets | IncreaseDecreaseThroughNetExchangeDifferencesPropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | -13,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughSharebasedPaymentTransactions | IncreaseDecreaseThroughSharebasedPaymentTransactions | EUR | 2.57M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets | IncreaseDecreaseThroughTransfersFromConstructionInProgressPropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill | IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment | IncreaseDecreaseThroughTransfersPropertyPlantAndEquipment | EUR | 0 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities | EUR | 1.10M | 2020-01-01 | 2020-01-31 | 2020 | FY | 20-F | 2021-04-27 | 0001628280-21-007629 |
| ifrs-full | IntangibleAssetsOtherThanGoodwill | IntangibleAssetsOtherThanGoodwill | EUR | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | InterestExpense | InterestExpense | EUR | 440,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | InterestExpenseIncomeNetDefinedBenefitLiabilityAsset | InterestExpenseIncomeNetDefinedBenefitLiabilityAsset | EUR | -27,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-04 | 0001598599-24-000020 |
| ifrs-full | InterestPaidClassifiedAsFinancingActivities | InterestPaidClassifiedAsFinancingActivities | EUR | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-04 | 0001598599-24-000020 |
| ifrs-full | InterestPaidClassifiedAsOperatingActivities | InterestPaidClassifiedAsOperatingActivities | EUR | 400,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | InterestReceivedClassifiedAsInvestingActivities | InterestReceivedClassifiedAsInvestingActivities | EUR | 388,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | InterestReceivedClassifiedAsOperatingActivities | InterestReceivedClassifiedAsOperatingActivities | EUR | 1.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | IssuedCapital | IssuedCapital | EUR | 4.69M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | IssueOfEquity | IssueOfEquity | EUR | 14.93M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | KeyManagementPersonnelCompensation | KeyManagementPersonnelCompensation | EUR | 4.38M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | KeyManagementPersonnelCompensationPostemploymentBenefits | KeyManagementPersonnelCompensationPostemploymentBenefits | EUR | 107,000 | 2025-01-01 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 |
| ifrs-full | KeyManagementPersonnelCompensationSharebasedPayment | KeyManagementPersonnelCompensationSharebasedPayment | EUR | 925,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | KeyManagementPersonnelCompensationShorttermEmployeeBenefits | EUR | 3.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | LeaseCommitmentsForShorttermLeasesForWhichRecognitionExemptionHasBeenUsed | EUR | 0 | 2018-12-31 | 2021 | FY | 20-F | 2022-04-04 | 0001628280-22-008197 | |
| ifrs-full | LeaseLiabilities | LeaseLiabilities | EUR | 3.27M | 2019-01-01 | 2021 | FY | 20-F | 2022-04-04 | 0001628280-22-008197 | |
| ifrs-full | LiabilityAssetOfDefinedBenefitPlans | LiabilityAssetOfDefinedBenefitPlans | EUR | 1.92M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NetDeferredTaxAssets | NetDeferredTaxAssets | EUR | 1.29M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | NetDeferredTaxLiabilities | NetDeferredTaxLiabilities | EUR | 1.29M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | NetForeignExchangeGain | NetForeignExchangeGain | EUR | 5.88M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | NetForeignExchangeLoss | NetForeignExchangeLoss | EUR | 2.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | NoncurrentAssets | NoncurrentAssets | EUR | 16.01M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities | NoncurrentDeferredIncomeIncludingNoncurrentContractLiabilities | EUR | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentFinancialAssets | NoncurrentFinancialAssets | EUR | 10.46M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentFinancialLiabilities | NoncurrentFinancialLiabilities | EUR | 13.77M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentLiabilities | NoncurrentLiabilities | EUR | 47.77M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentPrepayments | NoncurrentPrepayments | EUR | 0 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentProvisions | NoncurrentProvisions | EUR | 332,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentProvisionsForEmployeeBenefits | NoncurrentProvisionsForEmployeeBenefits | EUR | 1.92M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentReceivables | NoncurrentReceivables | EUR | 251,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NoncurrentRecognisedLiabilitiesDefinedBenefitPlan | NoncurrentRecognisedLiabilitiesDefinedBenefitPlan | EUR | 3.76M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | NumberOfEmployees | NumberOfEmployees | employee | 163 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NumberOfInstrumentsOtherEquityInstrumentsGranted | NumberOfInstrumentsOtherEquityInstrumentsGranted | pure | 4.74M | 2019-01-01 | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 |
| ifrs-full | NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement | NumberOfOtherEquityInstrumentsExercisableInSharebasedPaymentArrangement | pure | 4.81M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement | NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement | shares | 106,844 | 2024-06-10 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 | |
| ifrs-full | NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement | NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement | pure | 77,676 | 2019-01-01 | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 |
| ifrs-full | NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement | NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement | pure | 3.28M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | NumberOfSharesIssued | NumberOfSharesIssued | shares | 92.19M | 2025-04-24 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | NumberOfSharesOutstanding | NumberOfSharesOutstanding | shares | 79.54M | 2022-12-31 | 2022 | FY | 20-F | 2023-04-06 | 0001628280-23-010946 | |
| ifrs-full | OperatingExpense | OperatingExpense | EUR | 63.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherAdjustmentsForNoncashItems | OtherAdjustmentsForNoncashItems | EUR | 26,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 6-K | 2024-09-12 | 0001628280-24-040187 |
| ifrs-full | OtherAdjustmentsToReconcileProfitLoss | OtherAdjustmentsToReconcileProfitLoss | EUR | -2,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherComprehensiveIncome | OtherComprehensiveIncome | EUR | 1.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | EUR | 997,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | OtherComprehensiveIncomeNetOfTaxFinancialAssetsMeasuredAtFairValueThroughOtherComprehensiveIncome | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans | EUR | 94,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherCurrentPayables | OtherCurrentPayables | EUR | 1.02M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | OtherCurrentReceivables | OtherCurrentReceivables | EUR | 117,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | OtherIncome | OtherIncome | EUR | 13,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherLongtermBenefits | OtherLongtermBenefits | EUR | 479,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 |
| ifrs-full | OtherNoncurrentNonfinancialAssets | OtherNoncurrentNonfinancialAssets | EUR | 947,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | OtherOperatingIncomeExpense | OtherOperatingIncomeExpense | EUR | -1.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | OtherProvisions | OtherProvisions | EUR | 457,000 | 2020-12-31 | 2020 | FY | 20-F | 2021-04-27 | 0001628280-21-007629 | |
| ifrs-full | OtherReserves | OtherReserves | EUR | 1.12M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | OtherTaxEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome | EUR | 274,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ParValuePerShare | ParValuePerShare | EUR/shares | 0.05 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | PayablesOnSocialSecurityAndTaxesOtherThanIncomeTax | EUR | 6.55M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | PaymentsForShareIssueCosts | PaymentsForShareIssueCosts | EUR | 621,000 | 2020-01-01 | 2020-12-31 | 2022 | FY | 20-F | 2023-04-06 | 0001628280-23-010946 |
| ifrs-full | PaymentsFromPlanNetDefinedBenefitLiabilityAsset | PaymentsFromPlanNetDefinedBenefitLiabilityAsset | EUR | 281,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | PostemploymentBenefitExpenseDefinedContributionPlans | PostemploymentBenefitExpenseDefinedContributionPlans | EUR | 1.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProceedsFromBorrowingsClassifiedAsFinancingActivities | ProceedsFromBorrowingsClassifiedAsFinancingActivities | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProceedsFromIssuingShares | ProceedsFromIssuingShares | EUR | 14.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities | ProceedsFromOtherLongtermAssetsClassifiedAsInvestingActivities | EUR | 5,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProfitLoss | ProfitLoss | EUR | -49.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProfitLossBeforeTax | ProfitLossBeforeTax | EUR | -49.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProfitLossFromContinuingOperations | ProfitLossFromContinuingOperations | EUR | -49.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ProfitLossFromDiscontinuedOperations | ProfitLossFromDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | ProfitLossFromOperatingActivities | ProfitLossFromOperatingActivities | EUR | -54.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | PropertyPlantAndEquipment | PropertyPlantAndEquipment | EUR | 7.26M | 2023-06-30 | 2023 | Q2 | 6-K | 2023-09-14 | 0001628280-23-032230 | |
| ifrs-full | PropertyPlantAndEquipmentIncludingRightofuseAssets | PropertyPlantAndEquipmentIncludingRightofuseAssets | EUR | 4.36M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | Provisions | Provisions | EUR | 3.81M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ProvisionsForEmployeeBenefits | ProvisionsForEmployeeBenefits | EUR | 550,000 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities | PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities | EUR | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 20-F | 2024-04-04 | 0001598599-24-000020 |
| ifrs-full | PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities | PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities | PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities | EUR | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities | EUR | 140,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RawMaterialsAndConsumablesUsed | RawMaterialsAndConsumablesUsed | EUR | 2.75M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RecognisedAssetsDefinedBenefitPlan | RecognisedAssetsDefinedBenefitPlan | EUR | 0 | 2025-06-30 | 2025 | Q2 | 6-K | 2025-09-17 | 0001598599-25-000075 | |
| ifrs-full | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | EUR | 8.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | EUR | 43.62M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RetainedEarnings | RetainedEarnings | EUR | -134.91M | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | RetainedEarningsExcludingProfitLossForReportingPeriod | RetainedEarningsExcludingProfitLossForReportingPeriod | EUR | -386.37M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | RetainedEarningsProfitLossForReportingPeriod | RetainedEarningsProfitLossForReportingPeriod | EUR | -49.18M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | Revenue | Revenue | EUR | 9.01M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RevenueFromContractsWithCustomers | RevenueFromContractsWithCustomers | EUR | 2.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RevenueFromGovernmentGrants | RevenueFromGovernmentGrants | EUR | 19,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | RevenueFromSaleOfGoods | RevenueFromSaleOfGoods | EUR | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 6-K | 2022-09-15 | 0001628280-22-024942 |
| ifrs-full | ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | ReversalOfImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill | EUR | 41.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | SalesAndMarketingExpense | SalesAndMarketingExpense | EUR | 519,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | SellingGeneralAndAdministrativeExpense | SellingGeneralAndAdministrativeExpense | EUR | 19.72M | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | SharePremium | SharePremium | EUR | 408.03M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates | SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates | shares | 18,575 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | ShorttermEmployeeBenefitsExpense | ShorttermEmployeeBenefitsExpense | EUR | 21.91M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | SocialSecurityContributions | SocialSecurityContributions | EUR | 569,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 |
| ifrs-full | TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense | TaxBenefitArisingFromPreviouslyUnrecognisedTaxLossTaxCreditOrTemporaryDifferenceOfPriorPeriodUsedToReduceCurrentTaxExpense | EUR | 333,000 | 2018-01-01 | 2018-12-31 | 2020 | FY | 20-F | 2021-04-27 | 0001628280-21-007629 |
| ifrs-full | TaxExpenseIncomeAtApplicableTaxRate | TaxExpenseIncomeAtApplicableTaxRate | EUR | -12.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations | TaxExpenseRelatingToProfitLossFromOrdinaryActivitiesOfDiscontinuedOperations | EUR | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 20-F | 2025-04-30 | 0001598599-25-000042 |
| ifrs-full | TradeAndOtherCurrentPayables | TradeAndOtherCurrentPayables | EUR | 15.04M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | TradeAndOtherCurrentPayablesToTradeSuppliers | TradeAndOtherCurrentPayablesToTradeSuppliers | EUR | 7.47M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | TradeAndOtherCurrentReceivables | TradeAndOtherCurrentReceivables | EUR | 12.40M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | TradeAndOtherPayables | TradeAndOtherPayables | EUR | 15.04M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | TradeAndOtherReceivables | TradeAndOtherReceivables | EUR | 12.65M | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 | |
| ifrs-full | TravelExpense | TravelExpense | EUR | 748,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |
| ifrs-full | TreasuryShares | TreasuryShares | EUR | 18,575 | 2019-12-31 | 2019 | FY | 20-F | 2020-04-24 | 0001171843-20-002847 | |
| ifrs-full | WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 | WeightedAverageLesseesIncrementalBorrowingRateAppliedToLeaseLiabilitiesRecognisedAtDateOfInitialApplicationOfIFRS16 | pure | 0.02 | 2019-01-01 | 2021 | FY | 20-F | 2022-04-04 | 0001628280-22-008197 | |
| ifrs-full | WeightedAverageShares | WeightedAverageShares | shares | 89.59M | 2025-01-01 | 2025-12-31 | 2025 | FY | 20-F | 2026-04-01 | 0001598599-26-000005 |